| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUGGACAGGCCGCUGAAAGGAACCGGCUGCGGCCUGUGUGAGGCUCCGC… | 1939 nt | 0.4146 | |
| GACGCAGCUGGAGAGAAGUUAGAAGUGAUGCCACCAAAAAGAAAUGAAA… | 1781 nt | 0.3846 | |
| GUGGACAGGCCGCUGAAAGGAACCGGCUGCGGCCUGUGUGAGGCUCCGC… | 1885 nt | 0.4170 | |
| GUGGACAGGCCGCUGAAAGGAACCGGCUGCGGCCUGUGUGAGGCUCCGC… | 1988 nt | 0.4120 | |
| GUGGACAGGCCGCUGAAAGGAACCGGCUGCGGCCUGUGUGAGGCUCCGC… | 2076 nt | 0.4167 | |
| AGCAUUUCCAAACAGAGCAACUACAACCACUUCAAACAUCCUAAACUCC… | 2509 nt | 0.4018 | |
| AGCAUUUCCAAACAGAGCAACUACAACCACUUCAAACAUCCUAAACUCC… | 2440 nt | 0.3939 | |
| CUCGUCGCAGCGGCAGGUAGGAGGCGGUGCGCGCGGCCCGGCGACGGGG… | 1703 nt | 0.4022 | |
| CUCGUCGCAGCGGCAGGUAGGAGGCGGUGCGCGCGGCCCGGCGACGGGG… | 1773 nt | 0.3982 |
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]
A study in humans demonstrated that the VRK2 mRNA was up-regulated by 73% in pericontusional brain tissue from a patient with traumatic brain injury (patient T7) compared to control tissue, as identified via cDNA microarray analysis [Michael et al. DOI:10.1016/j.jocn.2004.11.003].